ondansetron has been researched along with Leukemia, Pre-B-Cell in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Excerpt | Relevance | Reference |
---|---|---|
"Ondansetron is a commonly used medication in the treatment of nausea and vomiting arising from many etiologies, including chemotherapy." | 7.74 | Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL. ( Pinsk, M; Turner, SR, 2008) |
"Ondansetron is a commonly used medication in the treatment of nausea and vomiting arising from many etiologies, including chemotherapy." | 3.74 | Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL. ( Pinsk, M; Turner, SR, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghafouri, N | 1 |
Darracq, MA | 1 |
Cantrell, FL | 1 |
Turner, SR | 1 |
Pinsk, M | 1 |
2 other studies available for ondansetron and Leukemia, Pre-B-Cell
Article | Year |
---|---|
Ondansetron-associated hypotension following pediatric self-poisoning.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Overdose; Emergencies; Huma | 2012 |
Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cytarab | 2008 |